Evonik Degussa Corporation: A Step Ahead of the Rest

As the world's leading specialty chemicals manufacturer Evonik Degussa Corporation offers a broad portfolio of products and services for the pharmaceutical market, covering the whole value chain from development to delivery.

Our products and services meet your requirements during the entire drug development process, from lead discovery via custom intermediates and APIs, excipients for drug formulations to drug delivery technologies. We provide leading edge technologies which create competitive advantage for our customers. Our business model is based on a partnership which fosters continuous improvement leading to intelligent and innovative solutions.

Our flexible organization and production facilities throughout the world enable us to be available for our customers anytime and anywhere. We come to meet and discuss your issues personally. Competent international teams and focused project management guarantee quick response and cost efficiency. Our facilities follow the highest technology and quality standards and, where required, follow cGMP standards.

Evonik Degussa for Pharma is your partner providing functional excipients for oral and topical dosage forms from one source including a wide range of products and formulation services. Our patented drug delivery technologies for solid oral dosage forms offer unique advantages in sustained release formulations and site specific drug delivery through the entire GI-tract. The different auxiliaries with very specific physico-chemical properties make your manufacturing highly cost effective.

Our novel and established drug delivery systems and clinical supply services combined with a highly professional project management make your drug development faster. Our reliable team of chemists, pharmacists, taste and flavor specialists and regulatory affairs experts accompany your drug formulation from preclinical through clinical manufacturing, to commercial manufacturing.

It’s to your advantage to learn more about our new AEROSIL® R972 Pharma Hydrophobic Colloidal Silicon Dioxide and how it increases productivity by providing a hydrophobic silica surface that serves as an excellent glidant with extremely low moisture absorption.

This new, standard in glidant performance is a high performing hydrophobic fumed silica that is easier to blend and disperse and offers a breakthrough in

flowability with less self-agglomeration. Other benefits include exceptional flow of cohesive powders, reduced caking and improved tablet dosage uniformity, resulting in higher throughput.

“AEROSIL® R972 Pharma Hydrophobic Colloidal Silicon Dioxide provides a better-quality performance than other industry glidants, reduces the need for sieving and fully complies with Ph.Eur. 6.0 and USP 31/NF 26 regulations,” said Paul Fox, Evonik’s Marketing Manager for Inorganic Materials.